期刊文献+

依普利酮对慢性心力衰竭大鼠血流动力学和运动能力的影响

Effects of Eplerenone on Hemodynamics and Exercise Capacity in Rats with Chronic Heart Failure
下载PDF
导出
摘要 目的探讨依普利酮对慢性心力衰竭大鼠血流动力学和运动能力的影响。方法将18只成年健康清洁级SD雄性大鼠随机分为空白组、心力衰竭组与依普利酮组,每组6只大鼠。心力衰竭组与依普利酮组均采用结扎左冠状动脉前降支建立心力衰竭模型,依普利酮组在心力衰竭模型建立后2周给予依普利酮20 mg/(kg·d)灌胃,连续应用4周。记录大鼠不同时间点的血流动力学和运动能力。结果所有大鼠都成活,心力衰竭组与依普利酮组实验2周、6周的收缩压与舒张压均明显高于空白组(P<0.05),依普利酮组实验6周的收缩压与舒张压均明显低于心力衰竭组(P<0.05)。实验6周,心力衰竭组与依普利酮组左室收缩末期内径(LVESD)明显高于空白组(P<0.05),依普利酮组LVESD低于心力衰竭组(P<0.05)。实验6周心力衰竭组与依普利酮组左室内压最大上升速率(+dp/dtmax)和左室内压最大下降速率(-dp/dtmax)值均低于空白组(P<0.05),依普利酮组+dp/dtmax、-dp/dtmax均高于心力衰竭组(P<0.05)。结论采用结扎左冠状动脉前降支建立心力衰竭模型能反映大鼠的心力衰竭状况,依普利酮可改善慢性心力衰竭大鼠血流动力学状况,提高心功能与运动能力。 Objective To investigate the effects of eplerenone on hemodynamics and exercise capacity in rats with chronic heart failure.Methods Eighteen adult healthy and clean SD male rats were divided into three groups:blank group,heart failure group,and eplerenone group,with 6 rats in each groups.The heart failure model in heart failure group and eplerenone group were established in by ligation of the left anterior descending coronary artery.The rats in eplerenone group were given eplerenone 20 mg/(kg·d)after the heart failure model establishment of 2 weeks,and the treatment were lasted for 4 weeks.The hemodynamics and exercise capacity of the rats at different time points were recorded.Results All rats were survived,the systolic and diastolic blood pressures in heart failure group and eplerenone group were significantly higher than those in blank group at 2 and 6 weeks(P<0.05).The systolic and diastolic pressures in eplerenone group were significantly lower than those of the heart failure group at 6 weeks(P<0.05).The left ventricular end systolic diameter(LVESD)of heart failure group and eplerenone group were significantly higher than that of blank group at 6 weeks(P<0.05),and the LVESD of eplerenone group was lower than that of the heart failure group(P<0.05).The+dp/dtmax and-dp/dtmax values of heart failure group and eplerenone group were lower than those of blank group at 6 weeks(P<0.05),and the+dp/dtmax and-dp/dtmax values of eplerenone group were higher than those of heart failure group(P<0.05).Conclusion The establishment of heart failure model by ligating the left anterior descending coronary artery can reflect the heart failure condition of rats.The application of eplerenone in chronic heart failure rats can improve hemodynamics and improve cardiac function and exercise capacity.
作者 卢小伟 LU Xiaowei(Dongfeng Hospital,Hubei University of Medicine,Shiyan 442008,Hubei,China)
出处 《中西医结合心脑血管病杂志》 2020年第17期2787-2790,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 慢性心力衰竭 依普利酮 血流动力学 运动能力 心功能 左室收缩末期内径 chronic heart failure eplerenone hemodynamics exercise capacity cardiac function left ventricular end systolic diameter
  • 相关文献

参考文献11

二级参考文献189

  • 1李旭,孟莹,姜泊,杨希山,王卫卫,郭丹,赖卓胜,张振书.血管紧张素Ⅱ和醛固酮对肝星状细胞核因子κB信号转导通路的影响[J].中华医学杂志,2005,85(6):374-380. 被引量:11
  • 2Mckelvie RS, Yusuf S, Pericak D, et al. Comparison of candesar-tan,enalapril,and their combination in congestive heart failure :randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators [ J]. Circulation, 1999 ; 100 : 1056 - 1064. 被引量:1
  • 3Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldo-sterone blocker, in patients with left ventricular dysfunction aftermyocardial infarction [ J ]. N Engl J Med,2003 ; 348 : 1309 -1321. 被引量:1
  • 4Pitt B, Ahmed A, Love TE, et al. History of hypertension andeplerenone in patients with acute myocardial infarction complicatedby heart failure[ J]. Hypertension ,200^ ;52 :271 -278. 被引量:1
  • 5Adamopoulos C,Ahmed A,Fay R,et al. Timing of eplerenone ini-tiation and outcomes in patients with heart failure after acute myo-cardial infarction complicated by left ventricular systolic dysfunc-tion: insights from the EPHESUS trial[ J]. Eur J Heart Fail,2009;11:1099-1105. 被引量:1
  • 6Kampourides N,Tziakas D, Chalikias G,et al. Usefulness of ma-trix metalloproteinase - 9 plasma levels to identify patients with pre-served left ventricular systolic function after acute myocardial infarc-tion who could benefit from eplerenone [ J ]. Am J Cardiol, 2012 ;110;1085 -1091. 被引量:1
  • 7Zannad F, Mcmurray JJ, Krum H, et al. Eplerenone in patientswith systolic heart failure and mild symptoms [ J ] . N Engl J Med,2011;364:11 -21. 被引量:1
  • 8Mak GJ, Ledwidge MT, Watson CJ, et al. Natural history of markersof collagen turnover in patients with early diastolic dysfunction andimpact of eplerenone[ J]. J Am Coll Cardiol ,2009 ;54 : 1674 -1682. 被引量:1
  • 9Pitt B, Reichek N, Willenbrock R, et al. Effects of eplerenone,enalapril,and eplerenone/enalapril in patients with essential hyper-tension and left ventricular hypertrophy : the 4E - left ventricular hy-pertrophy study [ J ] . Circulation,2003; 108:1831 -1838. 被引量:1
  • 10Suzuki G, Morita H, Mishima T, et al. Effects of long - termmonotherapy with eplerenone, a novel aldosterone blocker, on pro-gression of left ventricular dysfunction and remodeling in dogs withheart failure[ J]. Circulation t2002 ; 106 :2967 -2972. 被引量:1

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部